Global Life Science Tools and Reagents Market 2022-2028

September 2022 | 82 pages | ID: GA0710A6C6CDEN
Gen Consulting Company

Abstracts

The global life science tools and reagents market is expected to increase by USD 48 billion, at a compound annual growth rate (CAGR) of 7.2% from 2022 to 2028, according to the latest edition of the Global Life Science Tools and Reagents Market Report.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global life science tools and reagents market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the life science tools and reagents industry.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the product type, application, and region. The global market for life science tools and reagents can be segmented by product type: life science tools, life science COVID-19 diagnostics products. Life science tools and reagents market is further segmented by application: animal models, bioinformatics, cell biology, epigenetics, genomics, imaging and microscopy, proteomics, stem cells, others. Among these, the genomics segment was accounted for the highest revenue generator in 2021. Based on region, the life science tools and reagents market is segmented into: Asia Pacific, Europe, North America, Rest of the World (RoW).

By product type:

• life science tools
• life science COVID-19 diagnostics products

By application:

• animal models
• bioinformatics
• cell biology
• epigenetics
• genomics
• imaging and microscopy
• proteomics
• stem cells
• others

By region:

• Asia Pacific
• Europe
• North America
• Rest of the World (RoW)

The market research report covers the analysis of key stake holders of the global life science tools and reagents market. Some of the leading players profiled in the report include Abcam plc, Abnova Corp., Agilent Technologies Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Bio-Techne Corp., Bruker Corp., Carl Zeiss Inc., Charles River Laboratories Inc., Danaher Corp., GE Healthcare, GenOway S.A., Hitachi High-Tech Group, Illumina, Inc., JEOL Ltd., Labcorp Drug Development, Luminex Corporation, Merck KGaA (includes Sigma Aldrich), Novozymes Inc., Olympus Inc., Perkin Elmer Inc., Perkin Elmer Inc., Plus Therapeutics Inc., Qiagen N.V., Roche Holding AG, Shimadzu Corporation, Siemens Healthineers AG, Thermo Fisher Scientific Inc., Waters Corporation, among others.

*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period

This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.

Scope of the Report

• To analyze and forecast the market size of the global life science tools and reagents market.
• To classify and forecast the global life science tools and reagents market based on product type, application, region.
• To identify drivers and challenges for the global life science tools and reagents market.
• To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global life science tools and reagents market.
• To identify and analyze the profile of leading players operating in the global life science tools and reagents market.

Why Choose This Report

• Gain a reliable outlook of the global life science tools and reagents market forecasts from 2022 to 2028 across scenarios.
• Identify growth segments for investment.
• Stay ahead of competitors through company profiles and market data.
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.

Contents

PART 1. INTRODUCTION

Report description
Objectives of the study
Market segment
Years considered for the report
Currency
Key target audience

PART 2. METHODOLOGY

PART 3. EXECUTIVE SUMMARY

PART 4. MARKET OVERVIEW

Introduction
Drivers
Restraints
Impact of COVID-19 pandemic

PART 5. MARKET BREAKDOWN BY PRODUCT TYPE

Life science tools
Life science COVID-19 diagnostics products

PART 6. MARKET BREAKDOWN BY APPLICATION

Animal models
Bioinformatics
Cell biology
Epigenetics
Genomics
Imaging and microscopy
Proteomics
Stem cells
Others

PART 7. MARKET BREAKDOWN BY REGION

Asia Pacific
Europe
North America
Rest of the World (RoW)

PART 8. KEY COMPANIES

Abcam plc
Abnova Corp.
Agilent Technologies Inc.
Becton, Dickinson and Company
Bio-Rad Laboratories, Inc.
Bio-Techne Corp.
Bruker Corp.
Carl Zeiss Inc.
Charles River Laboratories Inc.
Danaher Corp.
GE Healthcare
GenOway S.A.
Hitachi High-Tech Group
Illumina, Inc.
JEOL Ltd.
Labcorp Drug Development
Luminex Corporation
Merck KGaA (includes Sigma Aldrich)
Novozymes Inc.
Olympus Inc.
Perkin Elmer Inc.
Perkin Elmer Inc.
Plus Therapeutics Inc.
Qiagen N.V.
Roche Holding AG
Shimadzu Corporation
Siemens Healthineers AG
Thermo Fisher Scientific Inc.
Waters Corporation
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER